HiPS-Cardiac Trilineage Cell Generation and Transplantation: a Novel Therapy for Myocardial Infarction
- 31 May 2019
- journal article
- review article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 13 (1) , 110-119
Abstract
Despite primary percutaneous coronary intervention (PPCI) and the availability of optimal medications, including dual antiplatelet therapy (DAPT), most patients still experience major adverse cardiovascular events (MACEs) due to frequent recurrence of thrombotic complications and myocardial infarction (MI). MI occurs secondary to a massive loss of endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and cardiomyocytes (CMs). The adult cardiovascular system gradually loses the ability to spontaneously and regularly regenerate ECs, VSMCs, and CMs. However, human cells can be induced by cytokines and growth factors to regenerate human-induced pluripotent stem cells (hiPSCs), which progress to produce cardiac trilineage cells (CTCs) such as ECs, VSMCs, and CMs, replacing lost cells and inducing myocardial repair. Nevertheless, the processes and pathways involved in hiPSC-CTC generation and their potential therapeutic effects remain unknown. Herein, we provide evidence of in vitro CTC generation, the pathways involved, in vivo transplantation, and its therapeutic effect, which may provide novel targets in regenerative medicine for the treatment of cardiovascular diseases (CVDs).Keywords
Funding Information
- National Natural Sciences Foundation of China, China (81100213,81470569)
This publication has 105 references indexed in Scilit:
- Functional Vascular Endothelium Derived from Human Induced Pluripotent Stem CellsStem Cell Reports, 2013
- Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic ratsInternational Journal of Cardiology, 2013
- Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signalingProceedings of the National Academy of Sciences, 2012
- WT1 regulates epicardial epithelial to mesenchymal transition through β-catenin and retinoic acid signaling pathwaysDevelopmental Biology, 2011
- Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutationEuropean Heart Journal, 2011
- Fibroblast Growth Factor-10 Promotes Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem CellsPLOS ONE, 2010
- High-Efficiency Induction of Neural Conversion in Human ESCs and Human Induced Pluripotent Stem Cells with a Single Chemical Inhibitor of Transforming Growth Factor Beta Superfamily ReceptorsStem Cells, 2010
- c-MYC-Independent Nuclear Reprogramming Favors Cardiogenic Potential of Induced Pluripotent Stem CellsJournal of Cardiovascular Translational Research, 2009
- An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiationJournal of Clinical Investigation, 2007
- The Wnt/β-catenin pathway regulates cardiac valve formationNature, 2003